[go: up one dir, main page]

NO951198L - Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene - Google Patents

Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene

Info

Publication number
NO951198L
NO951198L NO951198A NO951198A NO951198L NO 951198 L NO951198 L NO 951198L NO 951198 A NO951198 A NO 951198A NO 951198 A NO951198 A NO 951198A NO 951198 L NO951198 L NO 951198L
Authority
NO
Norway
Prior art keywords
derivatives
lipopeptide
preparation
lipopeptide derivatives
bacterial infections
Prior art date
Application number
NO951198A
Other languages
English (en)
Norwegian (no)
Other versions
NO951198D0 (no
Inventor
Rudolf Lattrell
Theodor Wollmann
Holger Wallmeier
Peter Hammann
Dieter Isert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO951198D0 publication Critical patent/NO951198D0/no
Publication of NO951198L publication Critical patent/NO951198L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO951198A 1994-03-30 1995-03-29 Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene NO951198L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411025A DE4411025A1 (de) 1994-03-30 1994-03-30 Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number Publication Date
NO951198D0 NO951198D0 (no) 1995-03-29
NO951198L true NO951198L (no) 1995-10-02

Family

ID=6514230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951198A NO951198L (no) 1994-03-30 1995-03-29 Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene

Country Status (24)

Country Link
US (1) US5629288A (zh)
EP (1) EP0688789B1 (zh)
JP (1) JP3653119B2 (zh)
KR (1) KR100360129B1 (zh)
CN (1) CN1111640A (zh)
AT (1) ATE219499T1 (zh)
AU (1) AU696566B2 (zh)
CA (1) CA2145826C (zh)
CZ (1) CZ287158B6 (zh)
DE (2) DE4411025A1 (zh)
DK (1) DK0688789T3 (zh)
ES (1) ES2178657T3 (zh)
FI (1) FI951468A7 (zh)
HU (1) HU218286B (zh)
IL (1) IL113160A (zh)
MA (1) MA23490A1 (zh)
NO (1) NO951198L (zh)
NZ (1) NZ270828A (zh)
OA (1) OA10142A (zh)
PL (1) PL180274B1 (zh)
PT (1) PT688789E (zh)
RU (1) RU2141970C1 (zh)
TW (1) TW336939B (zh)
ZA (1) ZA952555B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7067500B2 (en) * 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US6406880B1 (en) * 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
AU9464398A (en) * 1997-10-21 1999-05-10 Sankyo Company Limited Novel antifungal compounds
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
WO2000063239A1 (en) * 1999-04-16 2000-10-26 Sankyo Company, Limited Novel antifungal compounds
CN1423655A (zh) * 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的新颖的脂肽
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
JP4990456B2 (ja) 1999-12-15 2012-08-01 キュービスト ファーマシューティカルズ， インコーポレイテッド 抗菌剤としてのダプトマイシンアナログ
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
AU2001278933B2 (en) * 2000-07-17 2006-05-25 Migenix Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
CA2432096A1 (en) 2000-12-18 2002-08-01 Cubist Pharmaceuticals, Inc. Methods for preparing purified lipopeptides
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
ATE430160T1 (de) * 2001-08-06 2009-05-15 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
WO2003057724A1 (en) 2002-01-03 2003-07-17 Micrologix Biotech Inc. Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
CN1839150A (zh) 2003-07-17 2006-09-27 麦根克斯有限公司 脂肽抗菌衍生物组合物及其应用方法
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
TWI409077B (zh) * 2006-04-18 2013-09-21 Piramal Life Sciences Ltd 新穎抗菌化合物
US7888940B2 (en) * 2007-02-19 2011-02-15 Schlumberger Technology Corporation Induction resistivity cover
GB0821540D0 (en) * 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
NZ594019A (en) * 2008-12-22 2013-08-30 Cubist Pharm Inc Novel antibacterial agents for the treatment of gram positive infections
LT2504353T (lt) 2009-11-23 2018-09-25 Cubist Pharmaceuticals Llc Lipopeptidų kompozicijos ir susiję būdai
CN103554230B (zh) * 2013-09-18 2015-07-22 福建省微生物研究所 一种安福霉素类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
CA1337758C (en) * 1988-04-11 1995-12-19 Eli Lilly And Company Peptide antibiotics
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
RU95106362A (ru) 1996-12-27
ES2178657T3 (es) 2003-01-01
NZ270828A (en) 1996-10-28
FI951468L (fi) 1995-10-01
FI951468A7 (fi) 1995-10-01
TW336939B (en) 1998-07-21
PL307914A1 (en) 1995-10-02
KR950032636A (ko) 1995-12-22
OA10142A (fr) 1996-12-18
DE4411025A1 (de) 1995-10-05
KR100360129B1 (ko) 2003-03-26
EP0688789B1 (de) 2002-06-19
IL113160A (en) 1999-04-11
PL180274B1 (pl) 2001-01-31
ZA952555B (en) 1995-12-21
ATE219499T1 (de) 2002-07-15
NO951198D0 (no) 1995-03-29
RU2141970C1 (ru) 1999-11-27
MA23490A1 (fr) 1995-10-01
HK1012017A1 (zh) 1999-07-23
US5629288A (en) 1997-05-13
JP3653119B2 (ja) 2005-05-25
AU1611095A (en) 1995-10-12
CZ287158B6 (en) 2000-10-11
CZ77995A3 (en) 1995-10-18
CA2145826C (en) 2008-01-08
PT688789E (pt) 2002-11-29
AU696566B2 (en) 1998-09-10
IL113160A0 (en) 1995-06-29
DK0688789T3 (da) 2002-10-14
CA2145826A1 (en) 1995-10-01
HUT71584A (en) 1995-12-28
FI951468A0 (fi) 1995-03-28
EP0688789A1 (de) 1995-12-27
JPH07278186A (ja) 1995-10-24
DE59510246D1 (de) 2002-07-25
HU218286B (en) 2000-07-28
CN1111640A (zh) 1995-11-15

Similar Documents

Publication Publication Date Title
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG101118A (en) Therapeutical compounds
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
BG103947A (en) Derivatives of 9-oxymerythromycin
AU555444B2 (en) Cephalosporin derivatives
GR3036873T3 (en) Dialkyltiacumicin compounds
FI960658A0 (fi) Uudet bis-naftalimidit syövän hoitamiseksi
DK72289A (da) Cephemcarboxylsyreestere, deres fremstilling og anvendelse
AP9801235A0 (en) Erythromycin derivatives.
AU7411291A (en) Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
DK0390066T3 (da) Cephalosporinderivater og fremgangsmåde til deres fremstilling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application